Combined Microfracture Procedure Promotes Tendon Healing

Sponsor
Beijing Jishuitan Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05792202
Collaborator
(none)
50
1
2
48
1

Study Details

Study Description

Brief Summary

This study is a prospective randomized controlled study of Combined microfracture procedure promotes tendon healing during double raw repair for full tear rotator cuff. The patients with rotator cuff tear were randomly divided into groups before the operation. The patients were followed up before and 6 weeks, 3 months, 6 months, 12 months and 24months after surgery. In different time periods, the quantitative and qualitative indicators including pain, functional score, muscle strength, MRI performance, etc. were compared between groups at the same time period to evaluate the difference in the effect of double raw repair combined with microfracture on the treatment of rotator cuff.

Condition or Disease Intervention/Treatment Phase
  • Procedure: microfracture procedure
  • Procedure: only double raw repair
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Combined Microfracture Procedure Promotes Tendon Healing During Double Raw Repair for Full Tear Rotator Cuff - a Prospective Randomized Study With 2-year Follow-up
Anticipated Study Start Date :
Jun 1, 2023
Anticipated Primary Completion Date :
Jun 1, 2027
Anticipated Study Completion Date :
Jun 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: Study group

double raw repair for full tear rotator cuff combined microfracture procedure

Procedure: microfracture procedure
double raw repair combined with microfracture procedure which promotes tendon healing by releasing growth factors

Placebo Comparator: Control group

double raw repair for full tear rotator cuff

Procedure: only double raw repair
the double raw repair was used to repair the tendon tear

Outcome Measures

Primary Outcome Measures

  1. rotator cuff re-tear rate [2 year postoperatively]

    the rotator cuff re-tear rate was measured by MRI, MRI was performed to identify the status of the tendon

Secondary Outcome Measures

  1. VAS (Visual Analogue Scale) [1,2,3,7 days postoperatively and 3,6,12,24 months postoperatively]

    A score used to evaluate the pain

  2. ASES(American Shoulder and Elbow Surgeons'Form) [3,6,12,24 months postoperatively]

    A score used to evaluate the shoulder function

  3. Constant score [3,6,12,24 months postoperatively]

    A score used to evaluate the shoulder function

  4. UCLA (University LosAngeles scoring system) [3,6,12,24 months postoperatively]

    A score used to evaluate the shoulder function

  5. SST (simple shoulder test) [3,6,12,24 months postoperatively]

    A score used to evaluate the shoulder function

  6. front extension, external rotation and internal rotation strength of shoulder [6,12,24 months postoperatively]

    Use a dynamometer to measure in N

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Arthroscopy confirmed small to medium full rotator cuff tear

  • Unilateral rotator cuff injury

  • Voluntarily accept randomized controlled grouping, cooperate with treatment and follow up patients

  • Young and middle-aged patients aged 20 to 60

Exclusion Criteria:
  • Previous shoulder surgery (incision or arthroscopy)

  • Combined with diseases of other parts of the same limb

  • Combined with Bankart injury, acromioclavicular joint disease, greater tuberosity fracture, glenoid fracture and so on

  • Bilateral onset

  • Unable or unwilling to receive clinical follow-up

Contacts and Locations

Locations

Site City State Country Postal Code
1 Beijing Jishuitan hospital Beijing Beijing China 100000

Sponsors and Collaborators

  • Beijing Jishuitan Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yi Lu, Director of Sports Medicine Service of Beijing Jishuitan hospital, Beijing Jishuitan Hospital
ClinicalTrials.gov Identifier:
NCT05792202
Other Study ID Numbers:
  • LY
First Posted:
Mar 31, 2023
Last Update Posted:
Mar 31, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 31, 2023